Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
H&D Wireless Sweden Holding B | HDWB | 29. avr 2024 | 0.02 | +3.76 |
H&M B | HMB | 29. avr 2024 | 179.30 | -0.36 |
HAKI Safety A | HAKIA | 29. avr 2024 | 25.00 | 0.00 |
HAKI Safety B | HAKIB | 29. avr 2024 | 26.80 | +1.90 |
Hamlet BioPharma AB (publ) | HAMLETB | 29. avr 2024 | 2.48 | +5.53 |
Hansa Biopharma | HNSA | 29. avr 2024 | 29.00 | +6.15 |
Hanza AB | HANZA | 29. avr 2024 | 58.50 | +1.04 |
Harm Reduction Group | NOHARM | 29. avr 2024 | 0.13 | +0.77 |
Havsfrun Investment | HAVS | 29. avr 2024 | 13.35 | +2.30 |
Havsfrun Investment B | HAVB | 29. avr 2024 | 13.35 | +2.30 |
Haypp Group | HAYPP | 29. avr 2024 | 84.00 | +2.44 |
Headsent | VIMAB | 29. avr 2024 | 10.50 | +2.44 |
Heba B | HEBAB | 29. avr 2024 | 32.60 | +1.40 |
Hedera Group | HEGR | 29. avr 2024 | 5.85 | 0.00 |
Heimstaden Pref | HEIMPREF | 29. avr 2024 | 8.52 | -7.19 |
Heliospectra | HELIO | 29. avr 2024 | 0.44 | -1.12 |
Hemnet Group | HEM | 29. avr 2024 | 290.60 | +2.47 |
Hemply Balance | HMPLY | 29. avr 2024 | 0.04 | 0.00 |
Hexagon B | HEXAB | 29. avr 2024 | 120.50 | +0.25 |
Hexagon Purus | HPURO | 29. avr 2024 | 5.31 | +7.49 |
Hexatronic Group | HTRO | 29. avr 2024 | 33.55 | +5.37 |
Hexicon | HEXI | 29. avr 2024 | 0.60 | +6.00 |
Hexpol B | HPOLB | 29. avr 2024 | 125.60 | +3.49 |
Hifab B | HIFAB | 29. avr 2024 | 2.78 | 0.00 |
High Coast Distillery B | HIGHCOB | 29. avr 2024 | 46.00 | 0.00 |
Hilbert | HILBB | 29. avr 2024 | 3.78 | -7.80 |
HMS Networks | HMS | 29. avr 2024 | 419.20 | +0.77 |
Hoegh Autoliners ASA | HAUTOO | 29. avr 2024 | 102.40 | +1.17 |
Hoi Publishing AB | HOIB | 29. avr 2024 | 0.41 | -4.65 |
Hoist Finance | HOFI | 29. avr 2024 | 52.20 | +3.37 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.